Societal cost of rheumatoid arthritis patients in the US

Author： Birnbaum Howard   Pike Crystal   Kaufman Rebecca   Maynchenko Maryna   Kidolezi Yohanne   Cifaldi Mary  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.1, 2010-01, pp. : 77-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hearing status in patients with rheumatoid arthritis

By  

Journal of Laryngology and Otology, Vol. 131, Iss. 10, 2017-10 ,pp. : 895-899

Cambridge University Press

Access to resources Recommend Favorite

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

By Kielhorn Adrian   Porter Duncan   Diamantopoulos Alexander   Lewis Gavin  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2639-2650

Informa Healthcare

Access to resources Recommend Favorite

Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data

By Wu Eric   Chen Lei   Birnbaum Howard   Yang Elaine   Cifaldi Mary  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1749-1759

Informa Healthcare

Access to resources Recommend Favorite

Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross‐National Comparison Between the US and Taiwan

By  

ARTHRITIS CARE AND RESEARCH, Vol. 70, Iss. 1, 2018-01 ,pp. : 30-38

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost Effectiveness of Interferon-Gamma Release Assay for Tuberculosis Screening of Rheumatoid Arthritis Patients prior to Initiation of Tumor Necrosis Factor-α Antagonist Therapy

By Kowada Akiko  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 6, 2010-12 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite